News + PR
Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to Accelerate the Development of New Antibody Therapeutics
August 12, 2022
News & Media
Learn what’s new at Wheeler Bio
Filter By
Our Expert Team
Let’s Get Started
Wheeler is excited to collaborate on the path to accelerated clinical impact. Whether you’re an Innovator, a CRO, or a CDMO, we want to hear from you.